Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Kevin Debiparshad

Orthopaedic Surgery of the Spine Las Vegas, NV Medical Doctor

NPI 1710314968 CMS profile 258711

8180 Rafael Rivera Way Ste 100, Las Vegas, NV 89113

Open in the dashboard

General payments

$37,446

290 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Kevin Debiparshad of Las Vegas, NV is reported in the CMS Open Payments database as having received $37,446 across 290 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 65th percentile of Orthopaedic Surgery of the Spine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $9,834 82
2024 General $2,505 69
2023 General $7,042 59
2022 General $15,501 31
2021 General $944 19
2020 General $243 4
2019 General $1,376 26

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Kevin Debiparshad
  • Orthopaedic Surgery of the Spine median
  • Middle half of Orthopaedic Surgery of the Spine
  • National median

In program year 2025, general payments to Kevin Debiparshad were reported at $9,834. Among 1,704 Orthopaedic Surgery of the Spine profiles paid that year, the median was $2,061 and the middle half received between $347 and $14,651.

Show as a table
Year Kevin Debiparshad Orthopaedic Surgery of the Spine median Middle half National median
2019 $1,376 $2,106 $337–$18,608 $163
2020 $243 $1,213 $156–$15,082 $114
2021 $944 $1,834 $271–$15,617 $132
2022 $15,501 $2,015 $320–$17,036 $149
2023 $7,042 $1,925 $336–$14,599 $160
2024 $2,505 $2,110 $341–$12,483 $164
2025 $9,834 $2,061 $347–$14,651 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. NuVasive Specialized Orthopedics, Inc. $17,455 8 payments
  2. Providence Medical Technology, Inc. $10,777 91 payments
  3. Abbott Laboratories $1,722 28 payments
  4. BIOTRONIK NRO, Inc. $1,576 77 payments
  5. Orthofix Medical, Inc. $1,470 10 payments
  6. SI-BONE, Inc. $1,063 12 payments
  7. Globus Medical, Inc. $699 7 payments
  8. Boston Scientific Corporation $578 7 payments
  9. Stryker Corporation $542 19 payments
  10. Nevro Corp. $439 6 payments
  11. Other $1,124 25 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $21,300 4 payments
  2. Food and Beverage $11,804 275 payments
  3. Travel and Lodging $4,342 11 payments
Products named General payments · program years 2019–2025
  1. PRECICE Intramedullary Limb Lengthening System $17,247 6 payments
  2. M6-C $1,305 8 payments
  3. Prospera Not Applicable $831 31 payments
  4. Prospera Not Applicable $716 44 payments
  5. PENTA $577 11 payments
  6. IFUSE IMPLANT $436 5 payments
  7. PRECICE® Intramedullary Limb Lengthening System $355 3 payments
  8. Omnia $347 5 payments
  9. PROCLAIM $324 6 payments
  10. GENERAL PAIN MANAGEMENT $271 3 payments
  11. Other $3,341 63 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 4 drugs

Part D claims

83

Median for Orthopedic Surgery: 203

Drug cost

$910

Median for Orthopedic Surgery: $1,433

Branded share of claims

57.8%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 25 $521
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 23 $304
Tramadol Hcl Generic 21 $50
Meloxicam Generic 14 $34

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 105 billing codes

Paid by Medicare

$125,335

Medicare's payments for the services billed

Medicare patients

173

Average age 73

Services billed

922

102 women, 71 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 39%
Depression 35%
Chronic kidney disease 33%
Ischemic heart disease 32%
COPD 29%
Heart failure 23%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

290 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery of the Spine in Nevada

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record